Literature DB >> 21394639

Effect of N-acetyl-cysteine and hyperoxia on erythropoietin production.

Mona Momeni1, Marc De Kock, Olivier Devuyst, Giuseppe Liistro.   

Abstract

Previous studies in healthy subjects have shown an increase in erythropoietin (EPO) production after administration of N-acetyl-cysteine (NAC). These authors hypothesized that NAC increases intracellular reduced glutathione, decreasing reactive oxygen species and enabling EPO production. We investigated if EPO production could be stimulated with a single dose of NAC, after 90 min of pure oxygen breathing. Thirty-eight healthy volunteers were randomized into either the control (C) group or the NAC group, which received 600 mg NAC PO dissolved in a glass of orange juice, 60 min before breathing 15 L/min of 100% normobaric oxygen. Orange juice was administered to both groups. Blood samples for EPO measurement were taken at T0, before the orange juice administration, and T1, T2, T3 and T4, respectively, 8, 24, 32 and 48 h after the orange juice. The EPO concentrations of the NAC group decreased significantly at T1, followed by a significant increase compared to baseline, which was obvious until T4. The EPO concentrations of the C group did not show any significant variations. In this study, a significant increase of EPO production was observed after a short-term hyperoxic stimulus only when preceded with the administration of a single dose of NAC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394639     DOI: 10.1007/s00421-011-1893-4

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  29 in total

1.  Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway.

Authors:  P J Kallio; W J Wilson; S O'Brien; Y Makino; L Poellinger
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans.

Authors:  S M Freudenthaler; K-H Schreeb; A Wiese; J Pilz; C H Gleiter
Journal:  Acta Physiol Scand       Date:  2002-03

4.  Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anemia.

Authors:  S H Embury; J F Garcia; N Mohandas; R Pennathur-Das; M R Clark
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

5.  Acute normobaric hyperoxia transiently attenuates plasma erythropoietin concentration in healthy males: evidence against the 'normobaric oxygen paradox' theory.

Authors:  M E Keramidas; S N Kounalakis; T Debevec; B Norman; T Gustafsson; O Eiken; I B Mekjavic
Journal:  Acta Physiol (Oxf)       Date:  2011-03-18       Impact factor: 6.311

6.  Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization.

Authors:  Alexander Paliege; Christian Rosenberger; Anja Bondke; Lina Sciesielski; Ahuva Shina; Samuel N Heyman; Lee A Flippin; Michael Arend; Stephen J Klaus; Sebastian Bachmann
Journal:  Kidney Int       Date:  2009-12-16       Impact factor: 10.612

7.  The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males.

Authors:  A Zembron-Lacny; M Slowinska-Lisowska; Z Szygula; K Witkowski; K Szyszka
Journal:  Physiol Res       Date:  2008-12-17       Impact factor: 1.881

8.  Antioxidant intervention does not affect the response of plasma erythropoietin to short-term normobaric hypoxia in humans.

Authors:  A M Niess; E Fehrenbach; I Lorenz; A Müller; H Northoff; H-H Dickhuth; E M Schneider
Journal:  J Appl Physiol (1985)       Date:  2004-03

9.  Purification and characterization of hypoxia-inducible factor 1.

Authors:  G L Wang; G L Semenza
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

Review 10.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2009-04
View more
  7 in total

1.  Hypoxia, a multifaceted phenomenon: the example of the "normobaric oxygen paradox".

Authors:  C Balestra; P Germonpré
Journal:  Eur J Appl Physiol       Date:  2012-03-31       Impact factor: 3.078

2.  Prevailing evidence contradicts the notion of a "normobaric oxygen paradox".

Authors:  Michail E Keramidas; Ola Eiken; Igor B Mekjavic
Journal:  Eur J Appl Physiol       Date:  2012-03-31       Impact factor: 3.078

3.  Acute short-term hyperoxia followed by mild hypoxia does not increase EPO production: resolving the "normobaric oxygen paradox".

Authors:  Tadej Debevec; Michail E Keramidas; Barbara Norman; Thomas Gustafsson; Ola Eiken; Igor B Mekjavic
Journal:  Eur J Appl Physiol       Date:  2011-07-07       Impact factor: 3.078

Review 4.  Changing Perspectives from Oxidative Stress to Redox Signaling-Extracellular Redox Control in Translational Medicine.

Authors:  Paola Loreto Palacio; José R Godoy; Orhan Aktas; Eva-Maria Hanschmann
Journal:  Antioxidants (Basel)       Date:  2022-06-16

5.  Sub-anesthetic Xenon Increases Erythropoietin Levels in Humans: A Randomized Controlled Trial.

Authors:  Christian Stoppe; Julia Ney; Martin Brenke; Andreas Goetzenich; Christoph Emontzpohl; Gereon Schälte; Oliver Grottke; Manfred Moeller; Rolf Rossaint; Mark Coburn
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

6.  The mitochondria-targeted antioxidants and remote kidney preconditioning ameliorate brain damage through kidney-to-brain cross-talk.

Authors:  Denis N Silachev; Nikolay K Isaev; Irina B Pevzner; Ljubava D Zorova; Elena V Stelmashook; Svetlana V Novikova; Egor Y Plotnikov; Vladimir P Skulachev; Dmitry B Zorov
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

7.  Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases.

Authors:  Federica Rey; Alice Balsari; Toniella Giallongo; Sara Ottolenghi; Anna M Di Giulio; Michele Samaja; Stephana Carelli
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.